[Flow cytometric analysis of peripheral nerve tumors]

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Context:

• Peripheral nerve tumors represent a diverse group of neoplasms with varying clinical behaviors.
• Accurate classification and grading are crucial for determining prognosis and guiding treatment.
• Flow cytometry offers a quantitative method for assessing cellular DNA content and proliferation.

Purpose:

• To investigate the utility of flow cytometric DNA analysis in characterizing peripheral nerve tumors.
• To correlate DNA ploidy patterns and proliferative indices with tumor grade and prognosis.
• To differentiate between benign, actively proliferative, and malignant peripheral nerve tumors using these parameters.

Summary:

• Flow cytometric DNA analysis was conducted on 43 peripheral nerve tumor samples (14 benign, 11 proliferative, 12 malignant).
• Benign tumors exhibited diploid DNA content, while malignant and proliferative tumors showed increasing rates of DNA aneuploidy (75% and 25%, respectively).
• The proliferative index (PI) was significantly lower in benign tumors (median 24.8%) compared to proliferative (median 42.7%) and malignant tumors (median 51.2%).

Impact:

• Findings suggest that DNA ploidy and proliferative index are valuable objective markers for assessing the malignancy of peripheral nerve tumors.
• These flow cytometry parameters correlate with histologic grading and can aid in predicting patient prognosis.
• This study supports the integration of flow cytometry into the diagnostic workup of peripheral nerve tumors for improved classification and patient management.